A Conformational Switch in Nuclear Hormone Receptors Is Involved in Coupling Hormone Binding to Corepressor Release

REFERENCES

• Allenby, G., M.-T. Bocquel, M. Saunders, S. Kazmer, J. Speck, M. Rosenberger, A. Lovey, P. Kastner, J. F. Grippo, P. Chambon, and A. A. Levin. 1987. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA 90:30–34.
   Google Scholar
• Baniahmad, A., A. C. Kohne, and R. Renkawitz. 1992. A transferable silencing domain is present in the thyroid hormone receptor, in the v-Erb A oncogene product, and in the retinoic acid receptor. EMBO J. 11:1015–1023.
   PubMedGoogle Scholar
• Baniahmad, A., X. Leng, T. P. Burris, S. Y. Tsai, M. J. Tsai, and B. W. O’Malley. 1995. The v4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15:76–86.
   PubMedGoogle Scholar
• Beato, M., P. Herrlich, and G. Schutz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851–858.
   PubMed Web of Science ®Google Scholar
• Beck-Peccoz, P., and V. K. K. Chatterjee. 1994. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225–232.
   PubMedGoogle Scholar
• Bigler, J., and R. N. Eisenman. 1988. c-erbA encodes multiple proteins in chicken erythroid cells. Mol. Cell. Biol. 8:4155–4161.
   PubMedGoogle Scholar
• Bourguet, W., M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the ligand-binding domain of the human nuclear hormone receptor RXR alpha. Nature 375:377–382.
   PubMed Web of Science ®Google Scholar
• Casanova, J., E. Helmer, S. Selmi-Ruby, J. S. Qi, M. Au-Flieger, V. Desai-Yajnik, N. Koudinova, F. Yarm, B. M. Raaka, and H. H. Samuels. 1994. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoid acid receptors from an inhibitory cellular factor. Mol. Cell. Biol. 14:5756–5765.
   PubMedGoogle Scholar
• Chambon, P. 1994. The retinoid signaling pathway. Semin. Cell Biol. 5:115–125.
   PubMedGoogle Scholar
• Chen, H.-W., and M. L. Privalsky. 1993. The erbA oncogene represses the actions of both retinoid X and retinoid A receptors, but does so by distinct mechanisms. Mol. Cell. Biol. 13:5970–5980.
   PubMedGoogle Scholar
• Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454–457.
   PubMed Web of Science ®Google Scholar
• Chen, J. D., K. Umesono, and R. M. Evans. 1996. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. USA 93:7567–7571.
   PubMed Web of Science ®Google Scholar
• Collingwood, T. N., M. Adams, Y. Tone, and V. K. K. Chatterjee. 1994. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone þ receptors in thyroid hormone resistance syndrome. Mol. Endocrinol. 8:1262–1277.
   PubMedGoogle Scholar
• Damm, K., C. C. Thompson, and R. M. Evans. 1989. Protein encoded by v-Erb A functions as a thyroid hormone receptor antagonist. Nature 339:593–597.
   PubMed Web of Science ®Google Scholar
• de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RARa fusion mRNA encodes a functionally altered RAR. Cell 66:675–684.
   PubMed Web of Science ®Google Scholar
• Forman, B. M., K. Umesono, J. Chen, and R. M. Evans. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541–550.
   PubMed Web of Science ®Google Scholar
• Hall, B. L., Z. Smit-McBride, and M. L. Privalsky. 1993. Reconstitution of retinoid X receptor function and combinatorial regulation of other nuclear hormone receptors in the yeast, Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 90:6929–6933.
   PubMedGoogle Scholar
• Hayashi, R. 1977. Carboxypeptidase Y in sequence determination of peptides. Methods Enzymol. 47:84–93.
   PubMedGoogle Scholar
• Hong, S.-H., and M. L. Privalsky. Unpublished data.
   Google Scholar
• Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamel, M. Soderstrom, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397–404.
   PubMed Web of Science ®Google Scholar
• Horwitz, K. B., T. A. Jackson, D. L. Bain, J. K. Richer, G. S. Takimoto, and L. Tung. 1996. Nuclear hormone receptor coactivators and corepressors. Mol. Endocrinol. 10:1167–1177.
   PubMed Web of Science ®Google Scholar
• Hughes, M. R., P. J. Malloy, D. G. Kieback, R. A. Kesterson, J. W. Pike, D. Feldman, and B. W. O’Malley. 1993. Point mutations in the vitamin D receptor associated with hypocalcemic rickets. Science 242:1702–1705.
   Google Scholar
• Ikeda, M., E. C. Wilcox, and W. W. Chin. 1996. Different DNA elements can modulate the conformation of thyroid hormone receptor heterodimer and its transcriptional activity. J. Biol. Chem. 271:23096–23104.
   PubMedGoogle Scholar
• Kakizuka, A., W. H. Miller, K. Umesono, R. P. Warrell, S. R. Frankel, V. V. S. Murty, E. Dmitrovsky, and R. M. Evans. 1991. Chromosomal translocation t(15:17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor. Cell 66:663–674.
   PubMed Web of Science ®Google Scholar
• Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroidal nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859–870.
   PubMed Web of Science ®Google Scholar
• Keidel, S., P. LeMotte, and C. Apfel. 1994. Different agonist- and antagonistinduced conformational changes in retinoic acid receptors analyzed by protease mapping. Mol. Cell. Biol. 14:287–298.
   PubMed Web of Science ®Google Scholar
• Kopp, P., K. Kitajima, and J. L. Jameson. 1996. Syndrome of resistance to thyroid hormone: insights into thyroid hormone action. Proc. Soc. Exp. Biol. Med. 211:49–61.
   PubMed Web of Science ®Google Scholar
• Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. G. Rosenfeld, R. A. Heyman, and C. K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528–531.
   PubMed Web of Science ®Google Scholar
• Kurokawa, R., M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451–454.
   PubMed Web of Science ®Google Scholar
• Lazar, M. A. 1993. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocrinol. Rev. 14:184–193.
   PubMed Web of Science ®Google Scholar
• Leng, X., S. Y. Tsai, B. W. O’Malley, and M. J. Tsai. 1993. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor. J. Steroid Biochem. Mol. Biol. 46:643–661.
   PubMedGoogle Scholar
• Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841–850.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. Overview: the nuclear receptor superfamily: the second decade. Cell 83:835–840.
   PubMed Web of Science ®Google Scholar
• McPhaul, M. J., M. Marcelli, S. Zoppi, J. E. Griffin, and J. D. Wilson. 1993. Genetic basis of endocrine disease 4: the spectrum of mutations in the androgen receptor gene that cause androgen resistance. J. Clin. Endocrinol. Metab. 76:17–23.
   PubMed Web of Science ®Google Scholar
• Miner, J. N., M. I. Diamond, and K. R. Yamamoto. 1991. Transcriptional factor interactions: selectors of positive or negative regulation from a single DNA element. Cell Growth Differ. 2:525–530.
   PubMedGoogle Scholar
• Minucci, S., M. Leid, R. Toyama, J.-P. Saint-Jeannet, V. J. Peterson, V. Horn, J. E. Ishmael, N. Bhattacharyya, A. Dey, I. B. Dawid, and K. Ozato. 1997. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression. Mol. Cell. Biol. 17:644–655.
   PubMed Web of Science ®Google Scholar
• Pazin, M. J., and J. T. Kadonaga. 1997. What’s up and down with histone deacetylation and transcription? Cell 89:325–328.
   PubMed Web of Science ®Google Scholar
• Refetoff, S., R. E. Weiss, and S. Usala. 1993. The syndromes of resistance to thyroid hormone. Endocrine Rev. 14:348–399.
   PubMed Web of Science ®Google Scholar
• Renaud, J.-P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-μ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681–689.
   PubMed Web of Science ®Google Scholar
• Ribeiro, R. C., J. W. Apriletti, B. L. West, R. L. Wagner, R. J. Fletterick, F. Schaufele, and J. D. Baxter. 1993. The molecular biology of thyroid hormone action. Ann. N. Y. Acad. Sci. 758:366–389.
   Google Scholar
• Saatcioglu, F., P. Bartunek, T. Deng, M. Zenke, and M. Karin. 1993. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol. Cell. Biol. 13:3675–3685.
   PubMedGoogle Scholar
• Sande, S., and M. L. Privalsky. 1996. Identification of TRACs (T3 receptorassociating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol. Endocrinol. 10:813–825.
   PubMedGoogle Scholar
• Sap, J., A. Munoz, H. Schmitt, H. Stunnenberg, and B. Vennstrom. 1989. Repression of transcription mediated by a thyroid hormone response element by the v-Erb A oncogene product. Nature 340:242–244.
   PubMed Web of Science ®Google Scholar
• Schulman, I. G., H. Juguilon, and R. M. Evans. 1996. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell. Biol. 16:3807–3813.
   PubMed Web of Science ®Google Scholar
• Schulman, I. G., C. Li, J. W. R. Schwabe, and R. M. Evans. 1997. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev. 11:299–308.
   PubMed Web of Science ®Google Scholar
• Seol, W., H. S. Choi, and D. D. Moore. 1995. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9:72–85.
   PubMed Web of Science ®Google Scholar
• Seol, W., M. J. Mahon, Y. K. Lee, and D. D. Moore. 1996. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N- CoR. Mol. Endocrinol. 10:1646–1655.
   PubMedGoogle Scholar
• Tsai, M. J., and B. W. O’Malley. 1994. Molecular mechanisms of action of steroid/thyroid hormone receptor superfamily members. Annu. Rev. Biochem. 63:451–483.
   PubMed Web of Science ®Google Scholar
• Wagner, R. L., J. W. Apriletti, M. E. McGrath, B. L. West, J. D. Baxter, and R. J. Fletterick. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690–697.
   PubMed Web of Science ®Google Scholar
• Willy, P. J., and D. J. Mangelsdorf. 1997. Unique requirements for retinoid dependent transcriptional activation by the orphan receptor LXR. Genes Dev. 11:289–298.
   PubMedGoogle Scholar
• Wolffe, A. P. 1997. Transcriptional control—sinful repression. Nature 387:16–17.
   PubMed Web of Science ®Google Scholar
• Yoh, S. M., V. K. K. Chatterjee, and M. L. Privalsky. 1997. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol. Endocrinol. 11:470–480.
   PubMedGoogle Scholar
• Zamir, I., H. P. Harding, G. B. Atkins, A. Horlein, C. K. Glass, M. Rosenfeld, and M. A. Lazar. 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 16:5458–5465.
   PubMedGoogle Scholar
• Zamir, I., J. Zhang, and M. A. Lazar. 1997. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11:835–846.
   PubMed Web of Science ®Google Scholar